Target Company Overview

Suzhou Yilit Technology Co., Ltd. (hereinafter referred to as 'Yilit Technology') has recently completed its first round of financing, surpassing 100 million yuan. This round was led by Jifeng Capital and Suzhou High-tech Venture Capital, with participation from several investors including Guofa Venture Capital, Qiao Jing Capital, Lianxin Capital, Leibot Tech, and Qishi Dingfeng. Yilit Technology boasts over 30 years of experience in research and development (R&D) as well as transformation in the field of liquid chromatography instruments and related consumables, establishing itself as a leading domestic enterprise capable of independent research and volume production. As a pioneer in generating commercialized HPLC (High-Performance Liquid Chromatography) and chromatographic columns in China, Yilit has achieved a significant market share in the domestic HPLC sector, underpinned by the strategic utilization of more than a hundred core patents to secure independent intellectual property rights and local production.

Yilit Technology has played a key role in formulating national standards for liquid chromatography and has led the drafting of several HPLC national standards. This successful financing round reflects market confidence in Yilit's past achievements and recognition of its potential for future growth. The company is focused on developing a series of instruments and consumables for laboratory physical and chemical analysis, emerging biotechnology upstream purification, and clinical analytical diagnostics, emphasizing its commitment to the

View Source

Similar Deals

启明创投 蔚程医药有限公司

2025

Seed Stage Advanced Medical Equipment & Technology (NEC) China
启明创投 微滔生物科技(上海)有限公司

2025

Seed Stage Proprietary & Advanced Pharmaceuticals China
昆仑资本 和泽科技

2023

Seed Stage Bio Medical Devices China
光点资本 红瑞生物

2023

Seed Stage Biotechnology & Medical Research (NEC) China
Adicon Holdings Limited Crown Bioscience Inc.

2026

Other Biotechnology & Medical Research (NEC) China

济峰资本

invested in

依利特科技

in 2024

in a Seed Stage deal

Disclosed details

Transaction Size: $15M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert